Danish agency offers 14-day assessments for trial applications for marketed drugs
This article was originally published in SRA
Executive Summary
The Danish Health and Medicines Authority (formerly the Danish Medicines Agency) has introduced a new risk-adapted process that will allow the agency to assess clinical trial applications involving already marketed medicinal products more quickly1,2.